Author Correction: Jawsamycin exhibits in vivo antifungal properties by inhibiting Spt14/Gpi3-mediated biosynthesis of glycosylphosphatidylinositol.

Autor: Fu Y; Genomics Institute of the Novartis Research Foundation, 10675 John Jay Hopkins Drive, San Diego, CA, 92121, USA., Estoppey D; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Forum 1 Novartis Campus, CH-4056, Basel, Switzerland., Roggo S; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Forum 1 Novartis Campus, CH-4056, Basel, Switzerland., Pistorius D; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Forum 1 Novartis Campus, CH-4056, Basel, Switzerland., Fuchs F; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Forum 1 Novartis Campus, CH-4056, Basel, Switzerland., Studer C; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Forum 1 Novartis Campus, CH-4056, Basel, Switzerland., Ibrahim AS; The Lundquist Institute for Biomedical Innovations at Harbor-University of California at Los Angeles (UCLA) Medical Center, Torrance, CA, 90502, USA.; David Geffen School of Medicine at UCLA, Los Angeles, CA, 90095, USA., Aust T; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Forum 1 Novartis Campus, CH-4056, Basel, Switzerland., Grandjean F; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Forum 1 Novartis Campus, CH-4056, Basel, Switzerland., Mihalic M; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Forum 1 Novartis Campus, CH-4056, Basel, Switzerland., Memmert K; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Forum 1 Novartis Campus, CH-4056, Basel, Switzerland., Prindle V; Genomics Institute of the Novartis Research Foundation, 10675 John Jay Hopkins Drive, San Diego, CA, 92121, USA., Richard E; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Forum 1 Novartis Campus, CH-4056, Basel, Switzerland., Riedl R; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Forum 1 Novartis Campus, CH-4056, Basel, Switzerland., Schuierer S; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Forum 1 Novartis Campus, CH-4056, Basel, Switzerland., Weber E; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Forum 1 Novartis Campus, CH-4056, Basel, Switzerland., Hunziker J; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Forum 1 Novartis Campus, CH-4056, Basel, Switzerland., Petersen F; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Forum 1 Novartis Campus, CH-4056, Basel, Switzerland., Tao J; Genomics Institute of the Novartis Research Foundation, 10675 John Jay Hopkins Drive, San Diego, CA, 92121, USA. jtao@gnf.org., Hoepfner D; Novartis Institutes for BioMedical Research, Novartis Pharma AG, Forum 1 Novartis Campus, CH-4056, Basel, Switzerland. dominic.hoepfner@novartis.com.

Publikováno v: Nature communications [Nat Commun] 2020 Jul 31; Vol. 11 (1), pp. 3913. Date of Electronic Publication: 2020 Jul 31.

Synthesis and Anticancer Activity Assessment of Zelkovamycin Analogues.

Autor: Xie, Xinrong¹ (AUTHOR), Huang, Hongshun¹ (AUTHOR), Jaiswal, Yogini S.² (AUTHOR), Su, Shaoyang³ (AUTHOR), Yang, Linxia¹ (AUTHOR), Fan, Yu¹ (AUTHOR), Guan, Yifu¹ (AUTHOR) guanyifu@gxmzu.edu.cn, Williams, Leonard L.² (AUTHOR) guanyifu@gxmzu.edu.cn, Bian, Hedong¹ (AUTHOR) guanyifu@gxmzu.edu.cn

Publikováno v: Molecules. Sep2024, Vol. 29 Issue 18, p4483. 12p.

Inhibitors of Cyclophilin A: Current and Anticipated Pharmaceutical Agents for Inflammatory Diseases and Cancers.

Autor: Zhao, Xuemei¹ (AUTHOR) zhaoxm@sdfmu.edu.cn, Zhao, Xin¹ (AUTHOR) 18363429604@163.com, Di, Weihua¹ (AUTHOR), Wang, Chang^1,2 (AUTHOR) zhaoxm@sdfmu.edu.cn

Publikováno v: Molecules. Mar2024, Vol. 29 Issue 6, p1235. 24p.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

FR171456 is a specific inhibitor of mammalian NSDHL and yeast Erg26p.

Autor: Helliwell SB; Novartis Institutes for BioMedical Research, Novartis Campus, Basel, CH-4056, Switzerland., Karkare S; Novartis Institutes for BioMedical Research, Novartis Campus, Basel, CH-4056, Switzerland., Bergdoll M; Institut de Biologie Moléculaire des Plantes, CNRS, Unité Propre de Recherche 2357, Strasbourg cedex 67083, France., Rahier A; Institut de Biologie Moléculaire des Plantes, CNRS, Unité Propre de Recherche 2357, Strasbourg cedex 67083, France., Leighton-Davis JR; Novartis Institutes for BioMedical Research, Novartis Campus, Basel, CH-4056, Switzerland., Fioretto C; Novartis Institutes for BioMedical Research, Novartis Campus, Basel, CH-4056, Switzerland., Aust T; Novartis Institutes for BioMedical Research, Novartis Campus, Basel, CH-4056, Switzerland., Filipuzzi I; Novartis Institutes for BioMedical Research, Novartis Campus, Basel, CH-4056, Switzerland., Frederiksen M; Novartis Institutes for BioMedical Research, Novartis Campus, Basel, CH-4056, Switzerland., Gounarides J; Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts, 02139, USA., Hoepfner D; Novartis Institutes for BioMedical Research, Novartis Campus, Basel, CH-4056, Switzerland., Hofmann A; Novartis Institutes for BioMedical Research, Novartis Campus, Basel, CH-4056, Switzerland., Imbert PE; Novartis Institutes for BioMedical Research, Novartis Campus, Basel, CH-4056, Switzerland., Jeker R; Novartis Institutes for BioMedical Research, Novartis Campus, Basel, CH-4056, Switzerland., Knochenmuss R; Novartis Institutes for BioMedical Research, Novartis Campus, Basel, CH-4056, Switzerland., Krastel P; Novartis Institutes for BioMedical Research, Novartis Campus, Basel, CH-4056, Switzerland., Margerit A; Novartis Institutes for BioMedical Research, Novartis Campus, Basel, CH-4056, Switzerland., Memmert K; Novartis Institutes for BioMedical Research, Novartis Campus, Basel, CH-4056, Switzerland., Miault CV; Novartis Institutes for BioMedical Research, Novartis Campus, Basel, CH-4056, Switzerland., Rao Movva N; Novartis Institutes for BioMedical Research, Novartis Campus, Basel, CH-4056, Switzerland., Muller A; Novartis Institutes for BioMedical Research, Novartis Campus, Basel, CH-4056, Switzerland., Naegeli HU; Novartis Institutes for BioMedical Research, Novartis Campus, Basel, CH-4056, Switzerland., Oberer L; Novartis Institutes for BioMedical Research, Novartis Campus, Basel, CH-4056, Switzerland., Prindle V; GNF, San Diego, California 92121, USA., Riedl R; Novartis Institutes for BioMedical Research, Novartis Campus, Basel, CH-4056, Switzerland., Schuierer S; Novartis Institutes for BioMedical Research, Novartis Campus, Basel, CH-4056, Switzerland., Sexton JA; Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts, 02139, USA., Tao J; GNF, San Diego, California 92121, USA., Wagner T; Novartis Institutes for BioMedical Research, Novartis Campus, Basel, CH-4056, Switzerland., Yin H; Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts, 02139, USA., Zhang J; Novartis Institutes for BioMedical Research, Novartis Campus, Basel, CH-4056, Switzerland., Roggo S; Novartis Institutes for BioMedical Research, Novartis Campus, Basel, CH-4056, Switzerland., Reinker S; Novartis Institutes for BioMedical Research, Novartis Campus, Basel, CH-4056, Switzerland., Parker CN; Novartis Institutes for BioMedical Research, Novartis Campus, Basel, CH-4056, Switzerland.

Publikováno v: Nature communications [Nat Commun] 2015 Oct 12; Vol. 6, pp. 8613. Date of Electronic Publication: 2015 Oct 12.